Patent Number: 7,087,718

Title: C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereof

Abstract: A novel gene (designated PC-LECTIN) that is highly overexpressed in prostate cancer and its encoded protein is described. PC-LECTIN in normal human tissues is restricted to testis, but is highly expressed in prostate cancer. Consequently, PC-LECTIN provides a diagnostic and/or therapeutic target for prostate cancer.

Inventors: Afar; Daniel E. H. (Pacific Palisades, CA), Hubert; Rene S. (Los Angeles, CA), Jakobovits; Aya (Los Angeles, CA), Raitano; Arthur B. (Los Angeles, CA)

Assignee: Agensys, Inc.

International Classification: C07K 1/00 (20060101)

Expiration Date: 8/08/02018